FDA Adverse Event Injury Summary report: N

NALU NEUROSTIMULATION SYSTEM

MDR report key: 19988878 · Received August 15, 2024

Report

Report Number
3015425075-2024-00305
Event Type
Injury
Date Received
August 15, 2024
Date of Event
July 15, 2024
Report Date
August 14, 2024
Manufacturer
NALU MEDICAL INC
Product Code
GZF
UDI-DI
00812537036441
PMA / PMN Number
K183579
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
UT, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

FLUOROSCOPY IMAGING WAS USED AT THE TIME OF THE INITIAL IMPLANT TO ASSURE THE LEAD WAS AT THE DESIRED NERVE LOCATION FOR THERAPY AND THE PATIENT REPORTED GETTING SOME LEVEL OF PAIN RELIEF. AFTER USING THE SYSTEM FOR SEVERAL MONTHS IT BECAME APARENT THAT THE LOCATION OF THE LEAD WAS NOT TARGETING THE SOURCE OF THE PAIN AND NEEDED TO BE REPOSITIONED. FLUOUROSCOPIC IMAGING WAS USED DURING THE REVISION PROCEDURE AND THERE WAS NO INDICATION THAT THE LEAD HAD MOVED OR MIGRATED SINCE THE INITIAL IMPLANT. THERE DOES NOT APPEAR TO BE ANY ISSUE WITH THE NALU SYSTEM OR IT'S COMPONENTS. THE POSITION OF THE LEAD DURING THE IMPLANT DID NOT APPROPRIATELY TARGET THE LOCATION OF THE PATIENT'S PAIN AND REQUIRED ADJUSTMENT.

Description of Event or Problem · 0

PATIENT WAS IMPLANTED WITH A NALU PERIPHERAL NERVE STIMULATOR SYSTEM ON (B)(6)2023. AROUND (B)(6)2024 THE PATIENT REPORTED THAT THE STIMULATION FROM THE SYSTEM WAS BEING FELT TOO MUCH ON THE LATERAL SIDE AND THAT THE LOCATION OF PAIN WAS MORE MEDIAL. ON (B)(6)2024 A SURGICAL PROCEDURE TOOK PLACE IN WHICH THE PHYSICIAN REPOSITIONED THE EXISTING IMPLANTED LEAD TO MOVE IT MORE MEDIAL TO TARGET THE PATIENT'S PAIN LOCATION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1619507 NALU NEUROSTIMULATION SYSTEM PERIPHERAL NERVE STIMULATOR GZF NALU MEDICAL INC 71019 00812537036441

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown Other